未找到相关数据
Multicenter phase II trial of temsirolimus (TEM) and bevacizumab (BEV) in pancreatic neuroendocrine tumor (PNET)
被引：9
作者：
Hobday, Timothy J.
Qin, Rui
Reidy, Diane Lauren
Moore, Malcolm J.
Strosberg, Jonathan R.
Kaubisch, Andreas
Shah, Manisha H.
Kindler, Hedy Lee
Shah, Manisha H.
Lenz, Heinz-Josef
Kaubisch, Andreas
Chen, Helen X.
Erlichman, Charles
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Princess Margaret Hosp, Toronto, ON, Canada
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] H Lee Moffitt Canc Ctr Res Inst, Tampa, FL USA
[5] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[6] Ohio State Univ, Arthur G James Canc Hosp, Comprehens Canc Ctr, Columbus, OH USA
[7] Richard J Solove Res Inst, Columbus, OH USA
[8] Univ Southern Calif Norris, Comprehens Canc Ctr, Los Angeles, CA USA
[9] Albert Einstein Coll Med, Bronx, NY USA
[10] Montefiore Med Ctr, Bronx, NY USA
[11] CTEP Natl Canc Inst, Bethesda, MD USA
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
260
引用
收藏
页数：2
相关论文